Objective To determine when there is a notable difference in the chance of endophthalmitis after an intravitreal steroid injection in comparison to an anti-vascular endothelial development aspect agent (anti-VEGF) injection Design Retrospective cohort study Participants 75,249 beneficiaries in a big national US medical claims database representing 406,380 intravitreal injections Methods Data were sought out all… Continue reading Objective To determine when there is a notable difference in the